• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SANOFI / GENZYME CORPORATION SYNVISC 1; ACID, HYALURONIC, INTRAARTICULAR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SANOFI / GENZYME CORPORATION SYNVISC 1; ACID, HYALURONIC, INTRAARTICULAR Back to Search Results
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Pain (1994); Discomfort (2330); Ambulation Difficulties (2544); Swelling/ Edema (4577)
Event Date 12/06/2021
Event Type  Injury  
Event Description
Within 24 hours of the synvisc i injection, on (b)(6) 2021, i was unable to independently walk, drive or navigate my home.I experienced extreme and significant swelling of the knee, debilitating pain and tremendous fear that the condition i wanted to correct was made far worse.Despite intensive icing, four days after the injection, i was prescribed prednisone, which i had no effect.Day six of the injection and after three days of prednisone (sunday), my husband took me to the emergency pain clinic operated by the orthopedic practice.I was examined, the dosage of prednisone increased, and i was fitted with a brace.Thursday, (b)(6) 2021, my treating physician, withdrew fluid from the knee along with synvisc for analysis and indicated i had an extremely rare reaction to the synvisc.Today, (b)(6) 2021, i still have great pain and simply seek a return to my pre-injection status, mild but tolerable knee discomfort.With synvisc i expected some discomfort - but no disability.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SYNVISC 1
Type of Device
ACID, HYALURONIC, INTRAARTICULAR
Manufacturer (Section D)
SANOFI / GENZYME CORPORATION
MDR Report Key13059906
MDR Text Key282640351
Report NumberMW5106202
Device Sequence Number1
Product Code MOZ
Combination Product (y/n)N
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Voluntary
Reporter Occupation Patient
Type of Report Initial
Report Date 12/17/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received12/20/2021
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Was Device Available for Evaluation? No
Patient Sequence Number1
Treatment
NSAID'S AS NEEDED
Patient Outcome(s) Disability; Required Intervention;
Patient Age59 YR
Patient SexFemale
Patient Weight79 KG
Patient RaceBlack Or African American
-
-